Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry 'Revision: v3.6.3' was added to the Study Record History, replacing the previous 'Revision: v3.6.2'. This update reflects the latest version label in the history log without changing the study data or visible content.SummaryDifference0.1%

- Check17 days agoChange DetectedThe Study Record history now shows a newer revision (v3.6.2) replacing v3.6.0, indicating a minor behind-the-scenes update to the page.SummaryDifference0.1%

- Check32 days agoChange DetectedRecruitment status has changed to not recruiting participants, and the record history has been updated with a new v3.6.0 entry while removing the previous v3.5.5 entry.SummaryDifference0.3%

- Check39 days agoChange DetectedThe page history now records a new platform release version, Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates an underlying system update rather than changes to the study details displayed on the page.SummaryDifference0.1%

- Check60 days agoChange DetectedThe Record History now lists the latest revision as v3.5.4, replacing the previous v3.5.3. This reflects an update to the record's metadata without changing the underlying study data.SummaryDifference0.1%

- Check82 days agoChange DetectedThe page’s displayed UI revision label was updated from v3.5.2 to v3.5.3, reflecting a software/version change rather than a change to the underlying clinical trial record.SummaryDifference0.1%

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.